6D6-21866-07059 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-21
Dose 1 — Pfizer-BioNTech
2021-01-09
Registered in v-safe
2021-01-09
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-11
Dose 2 — Pfizer-BioNTech
2021-01-26
Survey response — day 14, dose 2
MedDRA: Fatigue, Headache — Feeling: Good

Free text: Headache, fatigue approximately 5 days after receding vaccine. Went away after 2 days.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-01
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-09
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-15
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-02-24
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-21	Pfizer-BioNTech
2	2021-01-11	Pfizer-BioNTech

Free text

Release 2 — day 14, dose 2

2021-01-26

Symptoms: Headache, fatigue approximately 5 days after receding vaccine. Went away after 2 days.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Fatigue	✓	✓	✓
SD	Headache	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release